Our founder, Michael Klein, is also the founder and managing partner of M. Klein and Company, which he founded in 2012. M. Klein and Company is a global strategic advisory firm that provides its clients a variety of advice tailored to their objectives.
In September 2018, we launched Churchill Capital Corp, a special purpose acquisition company (SPAC), which raised $690 million in its IPO and is listed on the New York Stock Exchange (NYSE:CCC). The company merged with Clarivate Analytics Plc (“Clarivate”), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, in May 2019.
Continuing the success of Churchill Capital Corp, we launched Churchill Capital Corp II, which raised $690 million in its IPO in June 2019. The company is listed on the New York Stock Exchange (NYSE: CCX.U) and is actively seeking an initial business combination.
In February 2020, Churchill Capital Corp III, our third SPAC, completed its $1.1 billion IPO. The company is listed on the New York Stock Exchange (NYSE:CCXX.U). On July 12, 2020, Churchill Capital Corp III announced a definitive agreement to merge with MultiPlan, Inc. (“MultiPlan”), a market-leading technology enabled provider of end-to-end healthcare cost management solutions.
In July 2020, Churchill Capital Corp IV, our fourth SPAC, completed its $2.07 billion IPO. The company is listed on the New York Stock Exchange (NYSE:CCIV.U).
Our strategy is to identify and complete our initial business combinations with a company in an industry that complements the experience and expertise of our management team, Board of Directors and Operating and Strategic Partners who are comprised of a group of individuals from leading Fortune 500 Companies. Our track record provides a highly attractive opportunity for prospective targets looking for proven, expedited access to liquidity, capital and value creation.